1. |
Veselka J, Anavekar NS, Charron P. Hypertrophic obstructive cardiomyopathy. Lancet, 2017, 389(10075): 1253-1267.
|
2. |
Kotkar KD, Said SM, Dearani JA, et al. Hypertrophic obstructive cardiomyopathy: The Mayo Clinic experience. Ann Cardiothorac Surg, 2017, 6(4): 329-336.
|
3. |
Pelliccia F, Pasceri V, Limongelli G, et al. Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol, 2017, 243: 379-384.
|
4. |
Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic cardiomyopathy: Echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg, 2003, 75(2): 620-632.
|
5. |
Brown ML, Schaff HV. Surgical management of obstructive hypertrophic cardiomyopathy: The gold standard. Expert Rev Cardiovasc Ther, 2008, 6(5): 715-722.
|
6. |
Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: Clinical update. JACC Heart Fail, 2018, 6(5): 364-375.
|
7. |
Afanasyev A, Bogachev-Prokophiev A, Lenko E, et al. Myectomy with mitral valve repair versus replacement in adult patients with hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg, 2019, 28(3): 465-472.
|
8. |
Price J, Clarke N, Turer A, et al. Hypertrophic obstructive cardiomyopathy: Review of surgical treatment. Asian Cardiovasc Thorac Ann, 2017, 25(9): 594-607.
|
9. |
Lawrance CP, Henn MC, Miller JR, et al. A minimally invasive Cox maze Ⅳ procedure is as effective as sternotomy while decreasing major morbidity and hospital stay. J Thorac Cardiovasc Surg, 2014, 148(3): 955-961.
|
10. |
姜兆磊, 梅举, 丁芳宝, 等. 微创右胸切口与常规胸骨正中切口主动脉瓣置换术的对比研究. 中国胸心血管外科临床杂志, 2014, 21(6): 762-765.
|
11. |
姜兆磊, 梅举, 汤敏, 等. 改良人工腱索技术在右胸微创切口二尖瓣成形术中的应用及效果评价. 中国心血管病研究, 2017, 15(5): 406-409, 后插1.
|
12. |
Roberts CS, McIntosh CL, Brown PS Jr, et al. Reoperation for persistent outflow obstruction in hypertrophic cardiomyopathy. Ann Thorac Surg, 1991, 51(3): 455-460.
|
13. |
Schwammenthal E, Nakatani S, He S, et al. Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: Mismatch of posterior to anterior leaflet length and mobility. Circulation, 1998, 98(9): 856-865.
|
14. |
Kwon DH, Setser RM, Thamilarasan M, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart, 2008, 94(10): 1295-1301.
|
15. |
Teo EP, Teoh JG, Hung J, et al. Mitral valve and papillary muscle abnormalities in hypertrophic obstructive cardiomyopathy. Curr Opin Cardiol, 2015, 30(5): 475-482.
|
16. |
Sherrid MV, Balaram S, Kim B, et al. The mitral valve in obstructive hypertrophic cardiomyopathy: A test in context. J Am Coll Cardiol, 2016, 67(15): 1846-1858.
|
17. |
Raffa GM, Romano G, Turrisi M, et al. Pathoanatomic findings and treatment during hypertrophic obstructive cardiomyopathy surgery: The role of mitral valve. Heart Lung Circ, 2019, 28(3): 477-485.
|
18. |
De Bonis M, Lapenna E, Taramasso M, et al. Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinical and echocardiographic results. J Thorac Cardiovasc Surg, 2014, 148(5): 2027-2032.
|
19. |
Alfieri O, Maisano F. An effective technique to correct anterior mitral leaflet prolapse. J Card Surg, 1999, 14(6): 468-470.
|
20. |
Obadia JF, Basillais N, Armoiry X, et al. Hypertrophic cardiomyopathy: The edge-to-edge secures the correction of the systolic anterior motion. Eur J Cardiothorac Surg, 2017, 51(4): 638-643.
|